---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-033358"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:05:35.996329+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# STRATA Skin Sciences announces clinical study showing TheraClear X reduces acne lesions by ≥50% after three treatments

## Summary
- Study in Journal of Cosmetic and Laser Therapy (July 11, 2024) evaluated 7 female patients with mild-moderate acne.
- All patients achieved ≥50% clearance of comedones, pustules, and inflammatory lesions after three treatments.
- Side effects were mild and transient: erythema, bruising, superficial erosions, temporary pigmentation changes (48-72 hours).
- TheraClear X is FDA-cleared as a noninvasive, in-office treatment for mild-to-moderate acne, combining vacuum and broadband light.
- President and CEO Dr. Dolev Rafaeli cited photopneumatic therapy as a viable alternative for patients resistant to traditional treatments.

## SEC filing metadata
- accession: 0001140361-24-033358
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036124033358/0001140361-24-033358-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036124033358/ef20032529_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-033358
- JSON: https://secwatch.observer/filing/0001140361-24-033358.json
- Plain text: https://secwatch.observer/filing/0001140361-24-033358.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.